Cemex CX Slides 395 as Selling Pressure Mounts 20260515 Ermenegildo ZGN Stock Analysis Falls 055 Watching 1198 20260515 Farmers FMNB Delivers Q1 2026 Beat EPS 045 vs 037 Expected VYNE Therapeutics VYNE Q4 2025 Earnings Surprise EPS 011 Up Significant Batam Emerges as Key Industrial Hub for Chinese Investment Singapore Remains Top Investor Biomerica BMRA Q1 2026 In Line Whats Next for Investors Strategy STRF Stock Steady at 10041 Support at 9539 20260520 TScan Therapeutics TCRX Stock Analysis 327 Gain What to Watch 20260520 SpaceX Successfully Launches Starship V3 the Largest Rocket in History on Key Test Flight UK Labours Capital Gains Tax Proposal Implications for Investors and Markets Kevin Warsh Takes the Helm at the Federal Reserve Amid Economic Pressures and Political Backlash Malaysian Food Startup Aims to Commercialize LabGrown Unagi Tesla CEO Highlights China as Key Rival in Humanoid Robot Race Senco Gold Q4 Profit Surges 151 to Rs 157 Crore on Strong Gold Prices and Wedding Demand Mamas Creations Inc MAMA Q1 2026 Earnings EPS Surpasses Estimates by 279 Amid Revenue and Guidance Gaps ADT Q1 2026 Earnings EPS Beats Estimates by 102 as Stock Edges Lower IMMR Q3 2025 Earnings Strong EPS Beat Driven by Licensing and Royalty Revenue RF Q1 2026 Earnings Slight EPS Beat Amidst Challenging Interest Rate Environment AVD Q3 2025 Earnings Massive EPS Miss Sends Stock Lower The real value proposition of AlTi Global ALTI stock 160 20260508 ALT Altimmune posts 105 revenue growth but misses Q4 earnings estimates by 102 sparking 675 stock decline How will Dr RDY earnings compare to expectations Q1 2026 Profit Surprises WRN Western meets Q4 2025 analyst EPS estimates registers modest share gains following earnings release EXAS Exact posts far wider than expected Q4 2025 loss shares remain unchanged in todays trading Is Hoth Therapeutics HOTH a once in a decade opportunity Weakens 20260508 UK Exports to US Plunge 25 Following Trump Liberation Day Tariffs UK Now Faces Trade Deficit with Largest Partner MRVI Q1 2026 Earnings EPS Surprise of 12079 Drives Focus on Cost Control Amid Revenue Uncertainties